Neural chips for Parkinson’s and epilepsy draw €4.4 million for London startup MintNeuro
MintNeuro, a British semiconductor company building specialised chips for neural devices from implants to wearables, today announces a €4.4 million ($5 million) round to accelerate product launch, expand delivery of pre-release silicon to partners and grow the company’s international presence. The round was led by Odyssey Ventures, with participation from 33East, JSK Investments and Alumni […]…
MintNeuro, a British semiconductor company, announced a €4.4 million ($5 million) investment round to advance its neural device technology. The funding, led by Odyssey Ventures, supports product launch, silicon delivery to partners, and international expansion. MintNeuro's co-founder and CEO, Dorian Haci, explains that current neural devices rely on either generic components or years of custom chip development, which MintNeuro aims to eliminate.
The company's modular semiconductor platform is designed for core functions like neural sensing, signal processing, and stimulation, enabling faster development of smaller, lower-power devices for conditions such as Parkinson's, epilepsy, depression, and more.
Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
